Stories

New Study Looks at Whether Spouses of Cancer Survivors Also Benefit From Exercise

June 09, 2010

Researchers in the Oregon Health & Science University Knight Cancer Institute are studying not only whether men with prostate cancer see the benefits of exercise (which could reduce side effects from their cancer treatment), but also whether spouses ...

OHSU Doernbecher Ranks Among Best Pediatric Cancer Hospitals in Nation

June 03, 2010

OHSU Doernbecher Children’s Hospital’s comprehensive pediatric oncology program ranks 28th out of 200 children’s cancer programs nationwide. This is the first year OHSU Doernbecher has applied to be ranked. “We are extremely proud of the care our ...

OHSU Doernbecher Ranks Among Best Pediatric Cancer Hospitals in Nation

June 03, 2010

OHSU Doernbecher Children’s Hospital’s comprehensive pediatric oncology program ranks 28th out of 200 children’s cancer programs nationwide. This is the first year OHSU Doernbecher has applied to be ranked. “We are extremely proud of the care our ...

Physicians Who Interpret Mammograms May Benefit From Additional Training

April 22, 2010

A multi-site study led by an Oregon Health & Science University Knight Cancer Institute researcher has identified set criteria that could be used to help identify physicians who might benefit from additional training in interpreting screening ...

Physicians Who Interpret Mammograms May Benefit From Additional Training

April 22, 2010

A multi-site study led by an Oregon Health & Science University Knight Cancer Institute researcher has identified set criteria that could be used to help identify physicians who might benefit from additional training in interpreting screening ...

Investigational Drug for Advanced Prostate Cancer Shows Promise

April 14, 2010

An investigational drug that’s shown promise in men with advanced prostate cancer will now move one step further in clinical development. In Phase II clinical trials, MDV3100 has been shown to effectively lower prostate specific antigen (PSA) levels — ...

Investigational Drug for Advanced Prostate Cancer Shows Promise

April 14, 2010

An investigational drug that’s shown promise in men with advanced prostate cancer will now move one step further in clinical development. In Phase II clinical trials, MDV3100 has been shown to effectively lower prostate specific antigen (PSA) levels — ...

OHSU Knight Cancer Institute Physician-Researcher Named LIVESTRONG® Senior Medical Adviser

April 09, 2010

Deepening its strong partnership with the Oregon Health & Science University Knight Cancer Institute, the cancer patient advocacy organization LIVESTRONG has selected Brandon Hayes-Lattin, M.D., as its senior medical adviser. Hayes-Lattin will advise ...

OHSU Knight Cancer Institute Physician-Researcher Named LIVESTRONG® Senior Medical Adviser

April 09, 2010

Deepening its strong partnership with the Oregon Health & Science University Knight Cancer Institute, the cancer patient advocacy organization LIVESTRONG has selected Brandon Hayes-Lattin, M.D., as its senior medical adviser. Hayes-Lattin will advise ...

OHSU Knight Cancer Institute Is First in Pacific Northwest to Perform TransOral Robotic Surgery

April 02, 2010

The OHSU Knight Cancer Institute has again pioneered some of the newest technology for head and neck cancer treatment in the Pacific Northwest. TransOral robotic surgery (TORS) removes tumors from the throat (oropharynx) and voicebox (larynx) while ...

Stories

OHSU in the News